Digestion formula
Natural health product licensed in Canada
- Other names
- Digest Formula
- Licence holder
- Canadian Phytopharmaceuticals Corporation
- NPN or DIN-HM
- 80066919
- Status
- Active licence
- Licence date
- 12 February 2016
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| myo-Inositol-hexakisphosphate 3-phosphohydrolase Source : Aspergillus niger - En entier | 1 mg | Not calculated |
| myo-Inositol-hexakisphosphate 3-phosphohydrolase Source : Aspergillus niger - En entier | 2 FCC PU | Not calculated |
| Gamma-oryzanol | 10 mg | Not calculated |
| Carica papaya Source : Fruit | 25 mg | Not calculated |
| Bromélaïne de fruit Source : Ananas comosus var. comosus - fruit | 10 mg | Not calculated |
| Althaea officinalis Source : Racine | 25 mg | Not calculated |
| L-Glutamine | 100 mg | Not calculated |
| bêta-galactosidase Source : Aspergillus flavus var. oryzae - En entier | 2.5 mg | Not calculated |
| bêta-galactosidase Source : Aspergillus flavus var. oryzae - En entier | 250 FCC ALU | Not calculated |
| Triacylglycérol lipase Source : Aspergillus flavus var. oryzae - En entier | 36 FCC LU | Not calculated |
| Triacylglycérol lipase Source : Aspergillus flavus var. oryzae - En entier | 11.25 mg | Not calculated |
| Pectin pectylhydrolase Source : Aspergillus flavus var. oryzae - En entier | 10 mg | Not calculated |
| Zingiber officinale Source : Rhizome | 25 mg | Not calculated |
| 4-alpha-D-glucane glucanohydrolase Source : Aspergillus flavus var. oryzae - En entier | 90 mg | Not calculated |
| 4-alpha-D-glucane glucanohydrolase Source : Aspergillus flavus var. oryzae - En entier | 7,650 FCC DU | Not calculated |
| 4-(1,3;1,4)-bêta-D-glucane 4-glucanohydrolase Source : Aspergillus flavus var. oryzae - En entier | 2 mg | Not calculated |
| 4-(1,3;1,4)-bêta-D-glucane 4-glucanohydrolase Source : Aspergillus flavus var. oryzae - En entier | 6,400 FCC CU | Not calculated |
| Protéase Source : Aspergillus flavus var. oryzae - En entier | 40 mg | Not calculated |
| Protéase Source : Aspergillus flavus var. oryzae - En entier | 2,020 FCC HUT | Not calculated |
| bêta-fructofuranosidase Source : Aspergillus niger - En entier | 40 FCC INVU | Not calculated |
| bêta-fructofuranosidase Source : Aspergillus niger - En entier | 0.5 mg | Not calculated |
| Diastase du malt Source : Aspergillus flavus var. oryzae - En entier | 12.5 mg | Not calculated |
| Diastase du malt Source : Aspergillus flavus var. oryzae - En entier | 120 FCC DP | Not calculated |
| Pectin pectylhydrolase Source : Aspergillus flavus var. oryzae - En entier | 60 Endo-PG | Not calculated |
Non-medicinal ingredients
Maltodextrine, Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | minimum: 1 day ; maximum: 3 days |
Uses authorised in Canada
Digestive enzymes.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Nausea, vomiting, and diarrhoea have been known to occur, in which case discontinue use (and consult a health care practitioner). Headaches, heartburn, bloating and hypersensitivity (e.g. allergy) have been known to occur; in which case, discontinue use.
- Précautions et mises en garde
If symptoms persist or worsen, consult a health care practitioner. If you are pregnant of breastfeeding, consult a health care practitioner prior to use. Consult a health care practitioner prior to use if you are following a low protein diet. If you have a gastrointestinal lesion/ ulcer, are taking an anticoagulant/ blood thinner, anti-inflammatory or antibiotic, or are having surgery, consult a health care practitioner prior to use. If you have diabetes, consult a health care practitioner prior to use.
Source
Official Health Canada record, licence 80066919
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.